NYSE Scores Teva Listing From Nasdaq – Wall Street Journal
 Wall Street Journal |
NYSE Scores Teva Listing From Nasdaq
Wall Street Journal By TESS STYNES And CHRIS DIETERICH The New York Stock Exchange scored its biggest defection as Teva Pharmaceutical Industries Ltd. said it will move its listing of US-traded shares to the Big Board from the Nasdaq Global Select Market in May. Teva Pharmaceutical Industries Ltd. to Transfer Listing to NYSE Teva to Transfer ADS Listing to NYSE From Nasdaq Market Drugmaker Teva to move listing to NYSE from Nasdaq |
